Indolo cyclopentane compound and synthesis method thereof
By synthesizing indole cyclopentane compounds under chiral phosphoric acid catalysis, the problem that indole cyclopentane compounds has not been studied has been solved, and high cytotoxic activity on human prostate cancer cells is achieved, which is suitable for use in the medical field. , and broaden the scope of application of synthesis methods.
Patent Information
- Application Number
- CN202410874027.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-02
- Publication Date
- 2024-12-03
- Estimated Expiration
- 2044-07-02
AI Technical Summary
Indole cyclopentane compounds have not been studied yet, and there is a lack of cytotoxicity study on human prostate cancer cell PC-3, so the prior art cannot effectively synthesize such compounds.
By using methyl-substituted 2-indole methanol and 3-substituted-2-indole methanol as the reaction raw material in an organic solvent, the reaction was stirred at 10-50°C under chiral phosphoric acid catalysis, and combined with TLC tracking, filtration and concentration , purify to obtain indole cyclopentane compounds. The reaction conditions are mild, simple and safe, with high diastereoselectivity and high yield.
Indole cyclopentane compounds with high sensitivity and cytotoxic activity to human prostate cancer cell PC-3 were obtained. They are suitable for use in the pharmaceutical field, and the scope of application of synthesis methods has been broadened, and are suitable for industrial large-scale production.
Smart Images

Figure CN119060057A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of indole compounds, and particularly relates to an indole cyclopentane compound and a synthesis method thereof. Background Art
[0002] Indole-cyclopentane compounds are widely found in anticancer drug molecules and natural products, and have broad application prospects in the field of life sciences. Combining indole and cyclopentane skeletons is expected to have good anti-tumor activity. However, at present, indole-cyclopentane compounds are a class of compounds that have never been studied, and no one has studied the synthesis methods of these compounds and their cytotoxicity to human prostate cancer cells PC-3. Summary of the invention
[0003] One of the purposes of the present invention is to provide an indole and cyclopentane compound to expand the type range of indole and cyclopentane compounds. The derivative has good sensitivity and cytotoxic activity to human prostate cancer cells PC-3.
[0004] The second object of the present invention is to provide a method for synthesizing the above-mentioned indolecyclopentane compounds, which has the advantages of mild reaction process, simplicity, safety and easy operation, high diastereoselectivity and enantioselectivity, and low cost and high yield.
[0005] To achieve the above object, on the one hand, the present invention provides an indole cyclopentane compound, the chemical structure of which is as follows:
[0006]
[0007] Wherein, Ar is independently selected from one of phenyl, methyl-substituted phenyl, methoxy-substituted phenyl, and thienyl; R is selected from one of hydrogen, halogen, and methyl; R 1 is independently selected from one of halogen-substituted phenyl, methyl-substituted phenyl, methoxy-substituted phenyl, naphthyl, thienyl, isopropyl, and cyclohexyl; R 2 are independently selected from hydrogen and methyl; R 3 Independently selected from one of phenyl, methyl, n-propyl and benzyl.
[0008] On the other hand, the present invention provides a method for synthesizing the above-mentioned indolecyclopentane compounds, which specifically comprises the following steps: adding methyl-substituted 2-indolemethanol and 3-substituted-2-indolemethanol as reaction raw materials into an organic solvent, stirring and reacting under the catalysis of chiral phosphoric acid and at a temperature of 10-50° C., tracking the reaction by TLC until completion, filtering, concentrating and purifying to obtain the indolecyclopentane compounds;
[0009] The molar ratio of the methyl-substituted 2-indole methanol to the 3-substituted-2-indole methanol is 2:(1-4), and the molar ratio of the methyl-substituted 2-indole methanol to the chiral phosphoric acid is (1-2):0.1;
[0010] The structural formula of the methyl-substituted 2-indolemethanol is Wherein, Ar is selected from one of phenyl, methyl-substituted phenyl, methoxy-substituted phenyl, and thienyl; R is selected from one of hydrogen, halogen, and methyl;
[0011] The structural formula of the 3-substituted-2-indolecarbinol is Among them, R 1 is selected from the group consisting of halogen-substituted phenyl, methyl-substituted phenyl, methoxy-substituted phenyl, naphthyl, thienyl, isopropyl, and cyclohexyl; R 2 is selected from hydrogen and methyl; R 3 One selected from phenyl, methyl, n-propyl and benzyl.
[0012] In an optional embodiment, the chiral phosphoric acid is selected from one of a binaphthyl skeleton derivative and an octahydrobinaphthyl skeleton derivative;
[0013] The structural formula of the binaphthyl skeleton derivative is Wherein G is selected from one of 4-chlorophenyl, 9-anthryl, 9-phenanthryl, 2,4,6-triisopropylphenyl, 2-naphthyl and 1-naphthyl;
[0014] The structural formula of the octahydrobinaphthyl skeleton derivative is In the formula, G' is selected from one of 9-phenanthrenyl, 9-anthryl, 2-naphthyl and 1-naphthyl.
[0015] In an optional embodiment, the chiral phosphoric acid is the octahydrobinaphthyl skeleton derivative, and the G' is selected from 9-anthryl.
[0016] In an optional embodiment, the organic solvent is selected from acetonitrile, acetone, ethyl acetate, and 1,2-dichloroethane.
[0017] In an optional embodiment, the ratio of the volume of the organic solvent to the molar amount of the methyl-substituted 2-indolemethanol is (5-40 mL): 1 mmol.
[0018] In an optional embodiment, the organic solvent is ethyl acetate, and the ratio of the volume of the ethyl acetate to the molar amount of the methyl-substituted 2-indolemethanol is 10 mL:1 mmol.
[0019] In an optional embodiment, the molar ratio between the methyl-substituted 2-indolemethanol and the 3-substituted-2-indolemethanol is 1:2.
[0020] In an optional embodiment, the reaction temperature is 30°C.
[0021] In an optional embodiment, the purification is performed by silica gel column chromatography, and the eluent is a petroleum / dichloromethane mixture in a volume ratio of 1:1.
[0022] Compared with the prior art, the present invention has at least the following beneficial effects:
[0023] The indole cyclopentane compounds synthesized by the present invention have been shown to have high sensitivity and strong cytotoxic activity to human prostate cancer cells PC-3 through biological activity tests, indicating that the indole cyclopentane compounds synthesized by the present invention are expected to be applied in the medical field;
[0024] The reaction conditions for synthesizing indolecyclopentane compounds are relatively conventional, the reaction process is mild, simple, easy to operate, low-cost, suitable for industrial large-scale production, and broadens the scope of application of the method; the present invention uses a variety of substrates as reactants to obtain products with diverse and complex structures, and has high yield, diastereoselectivity, and high enantioselectivity. BRIEF DESCRIPTION OF THE DRAWINGS
[0025] The accompanying drawings are used to provide a further understanding of the present application and constitute a part of the specification. Together with the following specific embodiments, they are used to explain the present application but do not constitute a limitation to the present application. In the accompanying drawings:
[0026] Figure 1 The synthetic route of the indole cyclopentane compound of formula 3aa of the exemplary embodiment 1 of the present invention is shown;
[0027] Figure 2 The synthetic route of 2-15 indole cyclopentane compounds of the exemplary embodiment of the present invention is shown;
[0028] Figure 3 The figure is a synthetic route diagram of indolecyclopentane compounds 16-21 according to exemplary embodiments of the present invention. DETAILED DESCRIPTION
[0029] The present invention is further described in detail below in conjunction with embodiments.
[0030] In the following examples, unless otherwise specified, methyl-substituted 2-indolecarbinol, 3-substituted-2-indolecarbinol, chiral phosphoric acid and other reagents can be purchased from the market or obtained according to known literature reports; the experimental methods are usually carried out under conventional conditions or conditions recommended by the manufacturer.
[0031] Example 1
[0032] The synthetic route of the indole cyclopentane compound 3aa is as follows: Figure 1 As shown, 0.05 mmol of methyl-substituted 2-indolemethanol 1a and 0.1 mmol of 3-substituted-2-indolemethanol 2a were added to the solvent as reactants, and under the action of 0.005 mmol (10 mol% of methyl-substituted 2-indolemethanol) chiral phosphoric acid 4 or 5, the reaction was stirred at 30°C for 5 hours, and the reaction was tracked by TLC until the end. After filtration and concentration, the reaction was purified and separated by silica gel column chromatography (the eluent was a mixed solution of petroleum ether and dichloromethane in a volume ratio of 1:1) to obtain an indolecyclopentane compound 3aa. The diastereoselectivity, yield and enantioselectivity are shown in Table 1.
[0033] Table 1 Effects of different types of chiral phosphoric acid, solvent, temperature, solvent volume, equivalent ratio on diastereoselectivity, enantioselectivity and yield of the reaction a
[0034]
[0035] Note: In Table 1, ee is the enantiomeric excess ratio.
[0036] From the data in Table 1, it can be concluded that the optimal reaction conditions are: the chiral phosphoric acid is formula 5d, the solvent is ethyl acetate, the volume of the organic solvent is 0.5 mL, and the reaction temperature is 30°C.
[0037] The structural characterization data of the product 3aa obtained under the optimal reaction conditions in Example 1 are as follows:
[0038] 95%yield(42.9mg)as a white solid.mp122.6–122.9℃;>95:5dr;[α] D 20 =39.5 (c = 0.86, acetone); 1 H NMR(400MHz, CDCl3)δ8.09(s,1H),7.59(d,J=8.0Hz,1H),7.55(d,J=8.0Hz,1H),7.39–7.33(m,4H),7.25–7.17(m,5H),7.14–7.08(m,4H), 6.93–6.88(m,1H),6.62(d,J=8.4Hz,1H),6.42(s,1H),4.63–4.56(m,1H),3.61–3.54(m,1H),3.25–3.14(m,1H),2.36(s,3H),2.00(s,3H); 13C NMR (100MHz, CDCl3) δ141.6,141.1,139.3,136.5,135.9,133.6,132.9,1 30.6,128.6,128.0,127.9,127.0,126.9,126.6,122.5,121.3,120.8,12 0.1,119.2,118.8,111.2,110.6,104.4,103.1,68.0,56.6,38.8,19.7,8 .7; IR(KBr):3566,3055,1558,1540,1489,1455,1338,1312,1298,746cm -1 ;ESI FTMS exact masscalcd for(C 33 H 28 N2-H) - requires m / z 451.2179, found m / z 451.2199; The enantiomeric excess: 93%, determined by HPLC (Daicel Chiralpak IB, hexane / isopropanol=90 / 10, flow rate 1.0mL / min, T=30℃, 254nm): t R =4.877(minor),t R =11.777(major).
[0039] Example 2-15
[0040] The synthesis method of Example 2-15 is the same as that of Example 1, except that 3-substituted-2-indolecarbinols with different structures are used as raw materials.
[0041] The reaction synthesis route is as follows Figure 2 The product, diastereoselectivity, enantioselectivity and yield are shown in Table 2 below:
[0042] Table 2 Reaction materials, products, diastereoselectivity, enantioselectivity, and yields of Examples 1 and 2-15
[0043]
[0044] Examples 16-21
[0045] The synthesis methods of Examples 16-21 are the same as those of Example 1, except that methyl-substituted 2-indolecarbinols of different structures are used as raw materials.
[0046] Its reaction synthesis route is as follows Figure 3The products, diastereoselectivity, enantioselectivity and yield are shown in Table 3 below.
[0047] Table 3 Reaction materials, products, diastereoselectivity, yield, enantioselectivity of Examples 16-21
[0048]
[0049] [a] The catalyst is formula (R)-4e, the catalytic amount is 20 mol%, and the ratio of formula 1 to formula 2 is 2:1.
[0050] As can be seen from Tables 2 and 3, the method of the present invention can not only realize the synthesis of indolecyclopentane compounds in one step, obtain extremely high diastereoselectivity, enantioselectivity and excellent yield, high atom economy, environmental friendliness, and a wide range of applications, but also has readily available raw materials, simple and safe operation, mild reaction conditions, short reaction time, simple post-treatment, and diversified product structures, and thus has great implementation value and potential social and economic benefits.
[0051] The indolecyclopentane compounds of the embodiments of the present invention were tested for their cytotoxic activity against human prostate cancer cells PC-3 using the MTT method, and the results are shown in Table 4. The results show that the compounds synthesized by the present invention have high cytotoxic activity against human prostate cancer cells PC-3.
[0052] Table 4 Cytotoxic activity of the compounds of the present invention against human prostate cancer cells PC-3
[0053]
[0054] Note: IC in Table 4 50 Refers to the half-maximal inhibitory concentration.
Claims
1. An indole cyclopentane compound, characterized in that: Its chemical structure is as follows: Wherein, Ar is independently selected from one of phenyl, methyl-substituted phenyl, methoxy-substituted phenyl, and thienyl; R is selected from one of hydrogen, halogen, and methyl; R 1 is independently selected from one of halogen-substituted phenyl, methyl-substituted phenyl, methoxy-substituted phenyl, naphthyl, thienyl, isopropyl, and cyclohexyl; R 2 are independently selected from hydrogen and methyl; R 3 Independently selected from one of phenyl, methyl, n-propyl and benzyl.
2. A method for synthesizing the indolecyclopentane compound as claimed in claim 1, characterized in that: The specific steps are: adding methyl-substituted 2-indolemethanol and 3-substituted-2-indolemethanol as reaction raw materials into an organic solvent, stirring and reacting under the catalysis of chiral phosphoric acid and at a temperature of 10-50° C., tracking the reaction by TLC until completion, filtering, concentrating and purifying to obtain the indolecyclopentane compound; The molar ratio of the methyl-substituted 2-indole methanol to the 3-substituted-2-indole methanol is 2:(1-4), and the molar ratio of the methyl-substituted 2-indole methanol to the chiral phosphoric acid is (1-2):0.1; The structural formula of the methyl-substituted 2-indolemethanol is Wherein, Ar is selected from one of phenyl, methyl-substituted phenyl, methoxy-substituted phenyl, and thienyl; R is selected from one of hydrogen, halogen, and methyl; The structural formula of the 3-substituted-2-indolecarbinol is Among them, R 1 is selected from the group consisting of halogen-substituted phenyl, methyl-substituted phenyl, methoxy-substituted phenyl, naphthyl, thienyl, isopropyl, and cyclohexyl; R 2 is selected from hydrogen and methyl; R 3 One selected from phenyl, methyl, n-propyl and benzyl.
3. The method for synthesizing indolecyclopentane compounds according to claim 2, characterized in that: The chiral phosphoric acid is selected from one of a binaphthyl skeleton derivative and an octahydrobinaphthyl skeleton derivative; The structural formula of the binaphthyl skeleton derivative is Wherein G is selected from one of 4-chlorophenyl, 9-anthryl, 9-phenanthryl, 2,4,6-triisopropylphenyl, 2-naphthyl and 1-naphthyl; The structural formula of the octahydrobinaphthyl skeleton derivative is In the formula, G' is selected from one of 9-phenanthrenyl, 9-anthryl, 2-naphthyl and 1-naphthyl.
4. The method for synthesizing indolecyclopentane compounds according to claim 3, characterized in that: The chiral phosphoric acid is the octahydrobinaphthyl skeleton derivative, and the G' is selected from 9-anthryl.
5. The method for synthesizing indolecyclopentane compounds according to claim 2, characterized in that: The organic solvent is selected from one of acetonitrile, acetone, ethyl acetate, 1,2-dichloroethane, toluene and tetrahydrofuran.
6. The method for synthesizing indolecyclopentane compounds according to claim 2, characterized in that: The ratio of the volume of the organic solvent to the molar amount of the methyl-substituted 2-indolemethanol is (5-40 mL): 1 mmol.
7. The method for synthesizing indolecyclopentane compounds according to claim 5, characterized in that: The organic solvent is ethyl acetate, and the ratio of the volume of the ethyl acetate to the molar amount of the methyl-substituted 2-indolemethanol is 10 mL:1 mmol.
8. The method for synthesizing indolecyclopentane compounds according to claim 2, characterized in that: The molar ratio between the methyl-substituted 2-indolecarbinol and the 3-substituted-2-indolecarbinol is 1:
2.
9. The method for synthesizing indolecyclopentane compounds according to claim 2, characterized in that: The reaction temperature is 30°C.
10. The method for synthesizing indolecyclopentane compounds according to claim 2, characterized in that: The purification is performed by silica gel column chromatography, and the eluent is a petroleum / dichloromethane mixture with a volume ratio of 1:1.
Citation Information
Patent Citations
Chiral indoline and pyrrole compound and synthesis method thereof
CN115385916A
Chiral indolo dihydropyridinoindole compound and synthesis method thereof
CN117820316A
